Locally Advanced Gastric Carcinoma: Clinical Trials

2 trials for Locally Advanced Gastric Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Completed 1

Follow Locally Advanced Gastric Carcinoma: new trials by email Literature Review of Locally Advanced Gastric Carcinoma trials Research Report on Locally Advanced Gastric Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
Azenosertib, Biopsy Procedure, Biospecimen Collection - Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)482025-02-032026-10-27
Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell
Bevacizumab, docetaxel oxaliplatin 5-FU CF, Gastrectomy - Locally Advanced Gastric Carcinoma
Phase 1 / Phase 2CompletedChinese PLA General Hospital862009-02-012014-04-25

Narrower conditions

Neoplasm Metastasis (1)  ·  Stomach Neoplasms (1)

Broader conditions

Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Stomach Diseases (1)

Interventions

Bevacizumab (1)  ·  Biopsy (1)  ·  Gastrectomy (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  trastuzumab deruxtecan (1)

Sponsors

Chinese PLA General Hospital (1)  ·  National Cancer Institute (NCI) (1)

Countries

China (1)  ·  United States (1)

Top investigators

Funda Meric-Bernstam (1)  ·  Nan Du, Phd (1)

NIH funding

UM1CA186688 (1)